Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV002493486 | SCV002777497 | uncertain significance | Recessive dystrophic epidermolysis bullosa; Pretibial dystrophic epidermolysis bullosa; Dominant dystrophic epidermolysis bullosa with absence of skin; Transient bullous dermolysis of the newborn; Epidermolysis bullosa pruriginosa; Nonsyndromic congenital nail disorder 8; Generalized dominant dystrophic epidermolysis bullosa | 2021-08-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003718394 | SCV004511598 | likely benign | not provided | 2023-10-06 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV005236756 | SCV005888127 | likely benign | not specified | 2025-01-19 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001278911 | SCV001465957 | uncertain significance | Epidermolysis bullosa dystrophica inversa, autosomal recessive | 2020-10-23 | no assertion criteria provided | clinical testing |